Suppr超能文献

西咪替丁与美托洛尔和普萘洛尔同时给药后两者的蓄积及不良反应

Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidine.

作者信息

Kirch W, Spahn H, Köhler H, Mutschler E

出版信息

Arch Toxicol Suppl. 1983;6:379-83. doi: 10.1007/978-3-642-69083-9_74.

Abstract

Pharmacokinetics of metoprolol, propranolol and atenolol were investigated in six healthy volunteers following 7 days of oral monotherapy with these drugs and after 7 days concurrent administration of each of these betareceptor antagonists with cimetidine. Application of cimetidine did not lead to any interaction with atenolol, whereas mean peak plasma levels of metoprolol were increased by 70%, and those of propranolol by 95% due to concurrent administration of cimetidine (p less than 0.05). The AUC of the two last mentioned beta blockers behaved similarly (p less than 0.05). Measurement of exercise-induced tachycardia on the 6th day of administration showed no differences between monotherapy with the beta blocker and combined treatment with each of them and cimetidine. Except for one volunteer who complained of anxiety, weakness and sweating on the 6th day of cimetidine/metoprolol administration, no adverse effects could be observed during the combination therapy with cimetidine and the beta blockers or in monotherapy with beta blockers.

摘要

在六名健康志愿者中研究了美托洛尔、普萘洛尔和阿替洛尔的药代动力学。这些志愿者分别接受了为期7天的上述药物口服单一疗法,以及在7天内将这些β受体拮抗剂与西咪替丁联合给药。西咪替丁的应用未导致与阿替洛尔发生任何相互作用,而由于与西咪替丁联合给药,美托洛尔的平均血浆峰值水平升高了70%,普萘洛尔的平均血浆峰值水平升高了95%(p<0.05)。上述两种β受体阻滞剂的曲线下面积表现相似(p<0.05)。在给药第6天对运动诱发的心动过速进行测量,结果显示β受体阻滞剂单一疗法与β受体阻滞剂分别与西咪替丁联合治疗之间无差异。除一名志愿者在西咪替丁/美托洛尔给药第6天抱怨出现焦虑、虚弱和出汗外,在西咪替丁与β受体阻滞剂联合治疗期间或β受体阻滞剂单一疗法期间均未观察到不良反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验